Congressman Andy Biggs | biggs.house.gov
Congressman Andy Biggs | biggs.house.gov
Today, Congressman Andy Biggs (R-AZ) expressed his concerns over the DNA testing process for illegal aliens encountered at the southern border. In a letter addressed to FBI Director Christopher Wray, Congressman Biggs highlighted the alleged 15-month analysis backlog, insufficient funds, and shortage of testing kits at CBP alien processing locations.
"Americans deserve to know who is coming across their border," emphasized Congressman Biggs. He further emphasized the need to identify individuals entering the country, especially with over 2.5 million encounters at the southern border in Fiscal Year 2023, including 169 individuals on the terror watch list.
Congressman Biggs criticized the FBI for not having a sufficient plan in place to provide quicker testing results and larger quantities of testing kits, calling the current situation "unacceptable." He eagerly awaits a response from Director Wray to gain a better understanding of the FBI's shortcomings in this matter.
The letter, co-signed by several other representatives, including Rep. Brian Babin (R-TX) and Rep. Anna Paulina Luna (R-FL), emphasizes the need for improved DNA testing procedures at the border. The cosigners are urging the FBI to take immediate action to address the existing challenges.
It is crucial to resolve these DNA testing woes to prevent criminal illegal aliens from freely moving throughout the country before law enforcement can act on the evidence gathered from the testing. The delays and shortages pose a significant threat to national security and the safety of American citizens.
The full letter can be read [here](insert link to the letter).
The concerns raised by Congressman Biggs and his fellow representatives shed light on the pressing issue of DNA testing at the southern border. As the number of encounters continues to rise, it becomes increasingly important to identify individuals entering the country and ensure the safety of American citizens. The FBI must respond promptly to address the existing challenges and provide a more efficient and effective DNA testing process at the border.